Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
Anquetil C, Hachulla E, Machuron F, Mariette X, Le Guern V, Vittecoq O, Dernis E, Larroche C, Dubost JJ, Perdriger A, Devauchelle-Pensec V, Fauchais AL, Morel J, Dieudé P, Rist S, Sene D, Gottenberg JE, Hatron PY. Anquetil C, et al. Among authors: hatron py. Rheumatology (Oxford). 2019 Jul 1;58(7):1163-1167. doi: 10.1093/rheumatology/key392. Rheumatology (Oxford). 2019. PMID: 30561748
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X. Gottenberg JE, et al. JAMA. 2014 Jul 16;312(3):249-58. doi: 10.1001/jama.2014.7682. JAMA. 2014. PMID: 25027140 Clinical Trial.
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X. Gottenberg JE, et al. Among authors: hatron py. PLoS One. 2013 May 24;8(5):e59868. doi: 10.1371/journal.pone.0059868. Print 2013. PLoS One. 2013. PMID: 23717383 Free PMC article.
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A. Cornec D, et al. Among authors: hatron py. Rheumatology (Oxford). 2015 Sep;54(9):1699-708. doi: 10.1093/rheumatology/kev114. Epub 2015 May 8. Rheumatology (Oxford). 2015. PMID: 25957440 Clinical Trial.
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?
Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A. Devauchelle-Pensec V, et al. Among authors: hatron py. PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015. PLoS One. 2015. PMID: 26368934 Free PMC article.
Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
Fauchais AL, Ouattara B, Gondran G, Lalloué F, Petit D, Ly K, Lambert M, Launay D, Loustaud-Ratti V, Bezanahari H, Liozon E, Hachulla E, Jauberteau MO, Vidal E, Hatron PY. Fauchais AL, et al. Among authors: hatron py. Rheumatology (Oxford). 2010 Jun;49(6):1164-72. doi: 10.1093/rheumatology/keq047. Epub 2010 Mar 18. Rheumatology (Oxford). 2010. PMID: 20299380
Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort study.
Costa S, Quintin-Roué I, Lesourd A, Jousse-Joulin S, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Pers JO, Marcorelles P, Nowak E, Saraux A, Devauchelle-Pensec V. Costa S, et al. Among authors: hatron py. Rheumatology (Oxford). 2015 Jun;54(6):1056-64. doi: 10.1093/rheumatology/keu453. Epub 2014 Nov 27. Rheumatology (Oxford). 2015. PMID: 25433039
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS).
Villon C, Orgeolet L, Roguedas AM, Misery L, Gottenberg JE, Cornec D, Jousse-Joulin S, Seror R, Berthelot JM, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Hayem G, Le Guern V, Perdriger A, Morel J, Vittecoq O, Mariette X, Devauchelle-Pensec V, Saraux A. Villon C, et al. Among authors: hatron py. Joint Bone Spine. 2021 Jul;88(4):105162. doi: 10.1016/j.jbspin.2021.105162. Epub 2021 Feb 19. Joint Bone Spine. 2021. PMID: 33617999 Clinical Trial.
442 results